{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:44:19Z","timestamp":1792575859319,"version":"4.5.0"},"reference-count":23,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Science OA"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/20565623.2026.2694330","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:59:19Z","timestamp":1782917959000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Treatment trajectories and patterns following non-medical switching to biosimilar adalimumab in patients with hidradenitis suppurativa: a retrospective observational multicenter study from Saudi Arabia"],"prefix":"10.1080","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2091-1376","authenticated-orcid":false,"given":"Ahmed","family":"Alamer","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz University","place":["Alkharj, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taibah","family":"AbuTaki","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Affairs, Dammam Medical Complex, Eastern Health Cluster","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shareefa Mohammed","family":"Alonaizi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Affairs, Dammam Medical Complex, Eastern Health Cluster","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalal Saadoun","family":"Alsaadoun","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Subdivision Department of Dermatology, College of Medicine, King Faisal university","place":["Alahsa, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukhtar","family":"Alomar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Affairs, Dammam Medical Complex, Eastern Health Cluster","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2025.04.009"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2025.2373"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.23029"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S493638"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20472"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13010048"},{"key":"e_1_3_6_8_1","unstructured":"FDA approves Novartis Cosentyx\u00ae as the first new biologic treatment option for hidradenitis suppurativa patients in nearly a decade | Novartis. [cited 2026 Feb 12]. Available from: https:\/\/www.novartis.com\/news\/media-releases\/fda-approves-novartis-cosentyx-first-new-biologic-treatment-option-hidradenitis-suppurativa-patients-nearly-decade."},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00101-6"},{"key":"e_1_3_6_10_1","unstructured":"FDA Approves Bimekizumab in Hidradenitis Suppurativa. [cited 2026 May 27]. Available from: AJMC. https:\/\/www.ajmc.com\/view\/fda-approves-bimekizumab-in-hidradenitis-suppurativa."},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2025.2484022"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.AD.2025.104531"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/24755303231212154"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-019-00355-4"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S478840"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdin.2025.05.023"},{"key":"e_1_3_6_17_1","unstructured":"Real-World Data Highlight Adalimumab Biosimilar Options for Hidradenitis Suppurativa. [cited 2026 Feb 15]. Available from: https:\/\/www.centerforbiosimilars.com\/view\/real-world-data-highlight-adalimumab-biosimilar-options-for-hidradenitis-suppurativa."},{"key":"e_1_3_6_18_1","unstructured":"STROBE - Strengthening the reporting of observational studies in epidemiology. [cited 2026 Feb 15]. Available from: https:\/\/www.strobe-statement.org\/."},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2024.2353693"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14387"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10102522"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18801"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/JDV.15235"}],"container-title":["Future Science OA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/20565623.2026.2694330","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/20565623.2026.2694330","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/20565623.2026.2694330","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:18:41Z","timestamp":1792574321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/20565623.2026.2694330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/20565623.2026.2694330"],"URL":"https:\/\/doi.org\/10.1080\/20565623.2026.2694330","relation":{},"ISSN":["2056-5623"],"issn-type":[{"value":"2056-5623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifso20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifso20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-03-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2694330"}}